Genomic studies have uncovered a claudin-low subtype of triple-negative breast cancer (TNBC), characterized by reduced expression of CLDN3 (claudin 3), CLDN4 (claudin 4), CLDN7 (claudin 7), and E-cadherin [106,107]. This evidence concerns the gene CLDN3 and triple-negative breast carcinoma.